Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)
Scope of the Report
The report titled “Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global CGM market. The report also gives an insight of the global CGM market by value, by penetration, by products, by components, by region, etc.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CGM market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in global CGM market is dominated by the two big players, DexCom Incorporation and Medtronic. Further, key players of the CGM market DexCom, Incorporation, Medtronic and Abbott Laboratories are also profiled with their financial information and respective business strategies.
Country Coverage
Continuous Glucose Monitoring (CGM) is a small glucose sensor (electrodes) inserted under the skin that keeps in check the glucose levels in interstitial fluid. The sensor stays in body for several days to a week before being replaced. A transmitter that is placed on the body sends information about the level of glucose via radio waves from the sensor to a wireless monitor that could be in the form of a wristband or it could be an app on the smartphone that allows the patient to view their glucose measurements. The CGM system basically has been designed to target the type1 diabetic population, for the early detection of hypo and hyperglycemia. The CGM system is made of three parts: a wireless monitor (receiver), a transmitter and a sensor. The CGM market has several advantages and disadvantages.
Global CGM market has increased at a significant CAGR during the years 2014-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The CGM market is expected to increase due to increasing population with type1 diabetes, sedentary lifestyle, rising population with obesity, etc. Yet, the market faces some challenges such as, intense competition in the market, lack of penetration in type 2 diabetes, lack of reliability and accuracy in data.
The report titled “Global Continuous Glucose Monitoring Market (CGM): Size, Trends & Forecasts (2016-2020)”, provides an in-depth analysis of the global CGM market. The report also gives an insight of the global CGM market by value, by penetration, by products, by components, by region, etc.
The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CGM market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
The competition in global CGM market is dominated by the two big players, DexCom Incorporation and Medtronic. Further, key players of the CGM market DexCom, Incorporation, Medtronic and Abbott Laboratories are also profiled with their financial information and respective business strategies.
Country Coverage
- North America
- Western Europe
- China
- Abbott Laboratories
- DexCom Incorporation
- Medtronic
Continuous Glucose Monitoring (CGM) is a small glucose sensor (electrodes) inserted under the skin that keeps in check the glucose levels in interstitial fluid. The sensor stays in body for several days to a week before being replaced. A transmitter that is placed on the body sends information about the level of glucose via radio waves from the sensor to a wireless monitor that could be in the form of a wristband or it could be an app on the smartphone that allows the patient to view their glucose measurements. The CGM system basically has been designed to target the type1 diabetic population, for the early detection of hypo and hyperglycemia. The CGM system is made of three parts: a wireless monitor (receiver), a transmitter and a sensor. The CGM market has several advantages and disadvantages.
Global CGM market has increased at a significant CAGR during the years 2014-2015 and projections are made that the market would rise in the next four years i.e. 2016-2020 tremendously. The CGM market is expected to increase due to increasing population with type1 diabetes, sedentary lifestyle, rising population with obesity, etc. Yet, the market faces some challenges such as, intense competition in the market, lack of penetration in type 2 diabetes, lack of reliability and accuracy in data.
1. EXECUTIVE SUMMARY
2. INTRODUCTION
2.1 Diabetes: An Overview
2.1.1 Types of Diabetes
2.1.2 Symptoms of Diabetes
2.1.3 Diagnosis of Diabetes
2.1.4 Treatment for Diabetes
2.1.5 Instruments/Gadgets/Apps to Manage Diabetes
2.1.6 Composition of Diabetes Device Market
2.2 Continuous Glucose Monitoring (CGM): An Overview
2.2.1 Advantages & Disadvantages of CGM
2.3 BGM v/s CGM
2.3.1 Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
3. GLOBAL MARKET ANALYSIS
3.1 Global Diabetes Market: An Analysis
3.1.1 Global Diabetic Population
3.1.2 Global Diabetic Population by Region
3.2 Global Diabetes Device Market: An Analysis
3.2.1 Global Diabetes Device Market/Glucose Monitoring Market by Value
3.2.2 Global Diabetes Device Market by Segments
3.3 Global CGM Market: An Analysis
3.3.1 Global CGM Market by Value
3.3.2 Global CGM Market by Segments
3.3.3 Global CGM Market by Regions
4. REGIONAL MARKET ANALYSIS
4.1 North America CGM Market: An Analysis
4.1.1 North America CGM Market by Value
4.1.2 US Diabetic Population
4.1.3 US Diabetic Population by Diagnosis
4.1.4 US Diabetes Population by Segments
4.1.5 US Type 1 Diabetic Population on the Basis of Management
4.1.6 US CGM Market by Patient & Penetration
4.2 Western Europe CGM Market: An Analysis
4.2.1 Western Europe CGM Market by Value
4.3 China CGM Market: An Analysis
4.3.1 China CGM Market by Value
4.3.2 China CGM Market by Segments
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increasing Population with Diabetes
5.1.2 Expanding Treatment Market for Type 1 Diabetes
5.1.3 Rising Population with Obesity
5.1.4 Factors Driving Recommendation for CGM
5.1.5 Sedentary Lifestyle
5.2 Challenges
5.2.1 Barriers to CGM Adoption by Type 1 Diabetes Patients
5.2.2 Discontinuation of CGM Use
5.2.3 Lack of Penetration in Type 2 Diabetes
5.2.4 Intense Competition
5.2.5 Regulatory Risk
5.3 Market Trends
5.3.1 Growing CGM Adoption
5.3.2 Smartphone Sales to End Users
5.3.3 CGM Penetration
5.3.4 The Reimbursement and Pricing Landscape
5.3.5 Innovation in CGM
6. COMPETITIVE LANDSCAPE
6.1 Global Competitive Landscape
6.1.1 Global CGM Market Players by CGM System Pricing
6.1.2 Global CGM Market Players by CGM Product Features
6.1.3 Global CGM Market Players by Share
6.2 US Competitive Landscape
6.2.1 US CGM Market Players by CGM Product Features
6.2.2 US CGM Market Players by Share (Volume)
6.2.3 US CGM Market Players by Product Preference
7. COMPANY PROFILE
7.1 Abott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 DexCom Incorporation
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Medtronic
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
2. INTRODUCTION
2.1 Diabetes: An Overview
2.1.1 Types of Diabetes
2.1.2 Symptoms of Diabetes
2.1.3 Diagnosis of Diabetes
2.1.4 Treatment for Diabetes
2.1.5 Instruments/Gadgets/Apps to Manage Diabetes
2.1.6 Composition of Diabetes Device Market
2.2 Continuous Glucose Monitoring (CGM): An Overview
2.2.1 Advantages & Disadvantages of CGM
2.3 BGM v/s CGM
2.3.1 Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
3. GLOBAL MARKET ANALYSIS
3.1 Global Diabetes Market: An Analysis
3.1.1 Global Diabetic Population
3.1.2 Global Diabetic Population by Region
3.2 Global Diabetes Device Market: An Analysis
3.2.1 Global Diabetes Device Market/Glucose Monitoring Market by Value
3.2.2 Global Diabetes Device Market by Segments
3.3 Global CGM Market: An Analysis
3.3.1 Global CGM Market by Value
3.3.2 Global CGM Market by Segments
3.3.3 Global CGM Market by Regions
4. REGIONAL MARKET ANALYSIS
4.1 North America CGM Market: An Analysis
4.1.1 North America CGM Market by Value
4.1.2 US Diabetic Population
4.1.3 US Diabetic Population by Diagnosis
4.1.4 US Diabetes Population by Segments
4.1.5 US Type 1 Diabetic Population on the Basis of Management
4.1.6 US CGM Market by Patient & Penetration
4.2 Western Europe CGM Market: An Analysis
4.2.1 Western Europe CGM Market by Value
4.3 China CGM Market: An Analysis
4.3.1 China CGM Market by Value
4.3.2 China CGM Market by Segments
5. MARKET DYNAMICS
5.1 Growth Drivers
5.1.1 Increasing Population with Diabetes
5.1.2 Expanding Treatment Market for Type 1 Diabetes
5.1.3 Rising Population with Obesity
5.1.4 Factors Driving Recommendation for CGM
5.1.5 Sedentary Lifestyle
5.2 Challenges
5.2.1 Barriers to CGM Adoption by Type 1 Diabetes Patients
5.2.2 Discontinuation of CGM Use
5.2.3 Lack of Penetration in Type 2 Diabetes
5.2.4 Intense Competition
5.2.5 Regulatory Risk
5.3 Market Trends
5.3.1 Growing CGM Adoption
5.3.2 Smartphone Sales to End Users
5.3.3 CGM Penetration
5.3.4 The Reimbursement and Pricing Landscape
5.3.5 Innovation in CGM
6. COMPETITIVE LANDSCAPE
6.1 Global Competitive Landscape
6.1.1 Global CGM Market Players by CGM System Pricing
6.1.2 Global CGM Market Players by CGM Product Features
6.1.3 Global CGM Market Players by Share
6.2 US Competitive Landscape
6.2.1 US CGM Market Players by CGM Product Features
6.2.2 US CGM Market Players by Share (Volume)
6.2.3 US CGM Market Players by Product Preference
7. COMPANY PROFILE
7.1 Abott Laboratories
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 DexCom Incorporation
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Medtronic
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
LIST OF FIGURES
Figure 1: Types of Diabetes
Figure 2: Symptoms of Diabetes
Figure 3: Instruments/Gadgets/Apps to Manage Diabetes
Figure 4: Composition of Diabetes Device Market
Figure 5: CGM System
Figure 6: Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
Figure 7: Global Diabetic Population; 2009-2020 (Million)
Figure 8: Regional Distribution of Global Diabetic Population; 2015
Figure 9: Global Diabetes Device Market/Glucose Monitoring Market by Value; 2014-2021 (US$ Billion)
Figure 10: Global Diabetes Device Market by Segments; 2015 and 2021
Figure 11: Global CGM Market by Value; 2014-2021 (US$ Million)
Figure 12: Global CGM Market by Segments; 2015
Figure 13: Global CGM Market by Regions; 2015
Figure 14: North America CGM Market by Value; 2015-2020 (US$ Million)
Figure 15: US Diabetic Population; 2013-2020 (Million)
Figure 16: US Diabetic Population by Diagnosis; 2015
Figure 17: US Diabetes Population by Segments; 2013-2020 (Million)
Figure 18: US Type 1 Diabetic Population on the Basis of Management; 2013-2020 (Million)
Figure 19: US Intensively Managed Type1 Diabetic Population by Segment; 2015-2020
Figure 20: US CGM Market by Patient & Penetration; 2013-2020 (Thousand)
Figure 21: Western Europe CGM Market by Value; 2015-2020 (US$ Million)
Figure 22: China CGM Market by Value; 2013-2024 (US$ Million)
Figure 23: China CGM Market by Segments; 2015-2024
Figure 24: Global Population with Diabetes; 2009-2014 (Million)
Figure 25: Global Treatment Market for Type 1 Diabetes; 2013-2023 (US$ Billion)
Figure 26: Global Population with Obesity; 2009-2014 (Million)
Figure 27: Barriers to CGM Adoption by Type 1 Diabetes Patients
Figure 28: CGM Adoption; 2016
Figure 29: Smartphone Sales to End Users; 2011-2015 (Million Units)
Figure 30: Global Players by Share; 2011-2015 (Percentage, %)
Figure 31: US CGM Market Players by Share; 2015-2020
Figure 32: US CGM Players by Product Preference; 2015
Figure 33: Abott Laboratories Net Sales; 2011-2015 (US$ Billion)
Figure 34: Abott Laboratories Net Sales by Segments; 2015
Figure 35: Dexcom Incorporation Revenue; 2011-2015 (US$ Million)
Figure 36: Dexcom Incorporation Revenue by Segments; 2015
Figure 37: Medtronic Net Sales; 2011-2015 (US$ Billion)
Figure 38: Medtronic Net Sales by Segments; 2015
Table 1: Factors Driving Recommendation for CGM
Table 2: Global CGM Market Players by CGM System Pricing
Table 3: Global CGM Market Players by CGM Product Features
Table 4: US CGM Market Players by CGM Product Features
Figure 1: Types of Diabetes
Figure 2: Symptoms of Diabetes
Figure 3: Instruments/Gadgets/Apps to Manage Diabetes
Figure 4: Composition of Diabetes Device Market
Figure 5: CGM System
Figure 6: Blood Glucose Monitoring (BGM) v/s Continuous Glucose Monitoring (CGM)
Figure 7: Global Diabetic Population; 2009-2020 (Million)
Figure 8: Regional Distribution of Global Diabetic Population; 2015
Figure 9: Global Diabetes Device Market/Glucose Monitoring Market by Value; 2014-2021 (US$ Billion)
Figure 10: Global Diabetes Device Market by Segments; 2015 and 2021
Figure 11: Global CGM Market by Value; 2014-2021 (US$ Million)
Figure 12: Global CGM Market by Segments; 2015
Figure 13: Global CGM Market by Regions; 2015
Figure 14: North America CGM Market by Value; 2015-2020 (US$ Million)
Figure 15: US Diabetic Population; 2013-2020 (Million)
Figure 16: US Diabetic Population by Diagnosis; 2015
Figure 17: US Diabetes Population by Segments; 2013-2020 (Million)
Figure 18: US Type 1 Diabetic Population on the Basis of Management; 2013-2020 (Million)
Figure 19: US Intensively Managed Type1 Diabetic Population by Segment; 2015-2020
Figure 20: US CGM Market by Patient & Penetration; 2013-2020 (Thousand)
Figure 21: Western Europe CGM Market by Value; 2015-2020 (US$ Million)
Figure 22: China CGM Market by Value; 2013-2024 (US$ Million)
Figure 23: China CGM Market by Segments; 2015-2024
Figure 24: Global Population with Diabetes; 2009-2014 (Million)
Figure 25: Global Treatment Market for Type 1 Diabetes; 2013-2023 (US$ Billion)
Figure 26: Global Population with Obesity; 2009-2014 (Million)
Figure 27: Barriers to CGM Adoption by Type 1 Diabetes Patients
Figure 28: CGM Adoption; 2016
Figure 29: Smartphone Sales to End Users; 2011-2015 (Million Units)
Figure 30: Global Players by Share; 2011-2015 (Percentage, %)
Figure 31: US CGM Market Players by Share; 2015-2020
Figure 32: US CGM Players by Product Preference; 2015
Figure 33: Abott Laboratories Net Sales; 2011-2015 (US$ Billion)
Figure 34: Abott Laboratories Net Sales by Segments; 2015
Figure 35: Dexcom Incorporation Revenue; 2011-2015 (US$ Million)
Figure 36: Dexcom Incorporation Revenue by Segments; 2015
Figure 37: Medtronic Net Sales; 2011-2015 (US$ Billion)
Figure 38: Medtronic Net Sales by Segments; 2015
Table 1: Factors Driving Recommendation for CGM
Table 2: Global CGM Market Players by CGM System Pricing
Table 3: Global CGM Market Players by CGM Product Features
Table 4: US CGM Market Players by CGM Product Features
